From chromosome ends to science advocacy
View more...
Antidepressant Pharmacogenetics
View more...
Realizing the Value of Precision Medicine: Today
View more...
Realizing the Potential of Precision Oncology
View more...
Mission Possible: Moving Diagnostics to the Forefront of Precision Medicine
View more...
Pharmacogenomics: Making the case for Primum non nocere
View more...
Innovative Methodologies to Drive Enrollment of Molecularly Defined Patient Populations for Diagnostic- Enabled Basket Studies
View more...
The first challenge of any population-scale research study is building a cohort of engaged participants.
View more...
Dr. Stephen Kingsmore – a vision for transforming medicine with rapid genome sequencing
View more...
The Diagnostics Year in Review - 2016
View more...
Tempus Announces BRCA Focused Initiative in Partnership with Penn’s Basser Center for BRCA

Tempus Announces BRCA Focused Initiative in Partnership with…

Tempus, a technology company focused on helping doctors personalize cancer treatment by collecting, sorting and analyzing…

Read More...
ChromaCode Raises $12 Million in Series B Funding for Commercial Launch and Appoints Alex Dickinson as Executive Chair

ChromaCode Raises $12 Million in Series B Funding for Commercial…

ChromaCode, Inc., a molecular diagnostics company, announced it has raised $12 million in Series B funding. This latest…

Read More...
WorldQuant Initiative for Quantitative Prediction established at Weill Cornell Medicine

WorldQuant Initiative for Quantitative Prediction established…

Weill Cornell Medicine has announced a gift made by WorldQuant, LLC (“WorldQuant”) and Igor Tulchinsky that…

Read More...
Diaceutics announces 30 jobs on back of 60% revenue growth

Diaceutics announces 30 jobs on back of 60% revenue growth

Diaceutics, the Irish data insights and solutions company enabling better patient testing globally, has announced 30 new…

Read More...
Top three global diagnostics company takes exclusive rights to several of Avacta’s Affimer reagents

Top three global diagnostics company takes exclusive rights…

Avacta Group plc (AIM: AVCT) (Avacta), the developer of Affimer® biotherapeutics and research reagents, is pleased to report…

Read More...
Verily Launches Landmark Study With Duke and Stanford as First Initiative of Project Baseline

Verily Launches Landmark Study With Duke and Stanford as First…

Verily Life Sciences LLC, an Alphabet company, in partnership with Duke University School of Medicine and Stanford Medicine,…

Read More...
Thermo Mass Spec May 2017

Video

Precision Medicine at Notre Dame

Notre Dame building a premier precision medicine group...

Read More...

The Power of Research

Cancer Research UK - bringing the power of research to everyone...

Read More...

Value of Medical Innovation

Medical innovation is a virtuous cycle that relies on investments from all stakeholders, patient access to treatment, and…

Read More...

Biogen Idec is Biogen, Once Again

One of the original biotech companies, Biogen has been anchored in Cambridge, MA for nearly four decades. Today, we remain…

Read More...

Novartis Targets Cancer Genomics for Precision Medicine

Go behind the scenes of the Next Generation Diagnostics group at the Novartis Institutes for BioMedical Research, and learn…

Read More...

Early Diagnosis of Genetic Diseases

Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with…

Read More...

 Tweets

 Blogs

Real “health care” happens when telemedicine is closely joined to a connected-care delivery model...

What are the factors driving change within the Autoimmune Disease IVD market? Autoimmune diseases...

As scientific progression continues its march forward, the word ‘separation’ is something that we...

PMLS 2017